SOST and diabetes mellitus: Nevertheless, PTH and both doses of ABL decreased bone mRNA Sost expression and ABL also reduced circulating sclerostin protein levels (Fig. 5a), suggesting a potential role of Sost/sclerostin downregulation in the anabolic function of the PTH1R ligands in the context of diabetes.